Medadvisor Ltd
ASX:MDR

Watchlist Manager
Medadvisor Ltd Logo
Medadvisor Ltd
ASX:MDR
Watchlist
Price: 0.29 AUD -3.33% Market Closed
Market Cap: 159.9m AUD
Have any thoughts about
Medadvisor Ltd?
Write Note

Intrinsic Value

The intrinsic value of one MDR stock under the Base Case scenario is 0.28 AUD. Compared to the current market price of 0.29 AUD, Medadvisor Ltd is Overvalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MDR Intrinsic Value
0.28 AUD
Overvaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medadvisor Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MDR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MDR?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Medadvisor Ltd

Provide an overview of the primary business activities
of Medadvisor Ltd.

What unique competitive advantages
does Medadvisor Ltd hold over its rivals?

What risks and challenges
does Medadvisor Ltd face in the near future?

Has there been any significant insider trading activity
in Medadvisor Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medadvisor Ltd.

Provide P/S
for Medadvisor Ltd.

Provide P/E
for Medadvisor Ltd.

Provide P/OCF
for Medadvisor Ltd.

Provide P/FCFE
for Medadvisor Ltd.

Provide P/B
for Medadvisor Ltd.

Provide EV/S
for Medadvisor Ltd.

Provide EV/GP
for Medadvisor Ltd.

Provide EV/EBITDA
for Medadvisor Ltd.

Provide EV/EBIT
for Medadvisor Ltd.

Provide EV/OCF
for Medadvisor Ltd.

Provide EV/FCFF
for Medadvisor Ltd.

Provide EV/IC
for Medadvisor Ltd.

Show me price targets
for Medadvisor Ltd made by professional analysts.

What are the Revenue projections
for Medadvisor Ltd?

How accurate were the past Revenue estimates
for Medadvisor Ltd?

What are the Net Income projections
for Medadvisor Ltd?

How accurate were the past Net Income estimates
for Medadvisor Ltd?

What are the EPS projections
for Medadvisor Ltd?

How accurate were the past EPS estimates
for Medadvisor Ltd?

What are the EBIT projections
for Medadvisor Ltd?

How accurate were the past EBIT estimates
for Medadvisor Ltd?

Compare the revenue forecasts
for Medadvisor Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medadvisor Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medadvisor Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medadvisor Ltd compared to its peers.

Compare the P/E ratios
of Medadvisor Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Medadvisor Ltd with its peers.

Analyze the financial leverage
of Medadvisor Ltd compared to its main competitors.

Show all profitability ratios
for Medadvisor Ltd.

Provide ROE
for Medadvisor Ltd.

Provide ROA
for Medadvisor Ltd.

Provide ROIC
for Medadvisor Ltd.

Provide ROCE
for Medadvisor Ltd.

Provide Gross Margin
for Medadvisor Ltd.

Provide Operating Margin
for Medadvisor Ltd.

Provide Net Margin
for Medadvisor Ltd.

Provide FCF Margin
for Medadvisor Ltd.

Show all solvency ratios
for Medadvisor Ltd.

Provide D/E Ratio
for Medadvisor Ltd.

Provide D/A Ratio
for Medadvisor Ltd.

Provide Interest Coverage Ratio
for Medadvisor Ltd.

Provide Altman Z-Score Ratio
for Medadvisor Ltd.

Provide Quick Ratio
for Medadvisor Ltd.

Provide Current Ratio
for Medadvisor Ltd.

Provide Cash Ratio
for Medadvisor Ltd.

What is the historical Revenue growth
over the last 5 years for Medadvisor Ltd?

What is the historical Net Income growth
over the last 5 years for Medadvisor Ltd?

What is the current Free Cash Flow
of Medadvisor Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medadvisor Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medadvisor Ltd

Current Assets 32.5m
Cash & Short-Term Investments 15.6m
Receivables 14.9m
Other Current Assets 2.1m
Non-Current Assets 66.3m
Long-Term Investments 962.4k
PP&E 442.1k
Intangibles 64.9m
Other Non-Current Assets 17k
Current Liabilities 45.7m
Accounts Payable 3.3m
Accrued Liabilities 5.4m
Other Current Liabilities 37m
Non-Current Liabilities 1.5m
Other Non-Current Liabilities 1.5m
Efficiency

Earnings Waterfall
Medadvisor Ltd

Revenue
122.1m AUD
Cost of Revenue
-47.9m AUD
Gross Profit
74.2m AUD
Operating Expenses
-71.6m AUD
Operating Income
2.7m AUD
Other Expenses
-1.9m AUD
Net Income
792.1k AUD

Free Cash Flow Analysis
Medadvisor Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MDR Profitability Score
Profitability Due Diligence

Medadvisor Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROE is Increasing
ROIC is Increasing
41/100
Profitability
Score

Medadvisor Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

MDR Solvency Score
Solvency Due Diligence

Medadvisor Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
50/100
Solvency
Score

Medadvisor Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDR Price Targets Summary
Medadvisor Ltd

Wall Street analysts forecast MDR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDR is 0.53 AUD with a low forecast of 0.45 AUD and a high forecast of 0.6 AUD.

Lowest
Price Target
0.45 AUD
57% Upside
Average
Price Target
0.53 AUD
84% Upside
Highest
Price Target
0.6 AUD
106% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MDR?

Click here to dive deeper.

Dividends

Medadvisor Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for MDR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MDR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Medadvisor Ltd Logo
Medadvisor Ltd

Country

Australia

Industry

Health Care

Market Cap

159.7m AUD

Dividend Yield

0%

Description

MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..

Contact

VICTORIA
Melbourne
L 2 971 Burke Road, Camberwell
www.medadvisor.com.au

IPO

2011-05-26

Employees

-

Officers

CEO, MD & Director
Mr. Richard Ratliff
CFO & Joint Company Secretary
Ms. Ancila Desai B.Com., C.A., M.B.A.
Acting Chief Technology Officer
Mr. Craig Schnuriger
Executive VP of US & Client Relations
Mr. James M. Rotsart R.Ph.
President of ANZ
Mr. Wayne Marinoff
Joint Company Secretary
Ms. Anshu Raghuvanshi L.L.B.

See Also

Discover More
What is the Intrinsic Value of one MDR stock?

The intrinsic value of one MDR stock under the Base Case scenario is 0.28 AUD.

Is MDR stock undervalued or overvalued?

Compared to the current market price of 0.29 AUD, Medadvisor Ltd is Overvalued by 5%.

Back to Top